Drugs.com - Pharma Industry News

Circulating Tumor DNA Can ID Outcomes for Patients With Melanoma

WEDNESDAY, April 16, 2025 -- Droplet digital polymerase chain reaction (PCR) measurements of cell-free, circulating tumor DNA (ctDNA) can identify patients with melanoma and a high risk for recurrence before adjuvant targeted therapy, according to...

Apr 16, 2025 - 21:53
 0
Circulating Tumor DNA Can ID Outcomes for Patients With Melanoma
WEDNESDAY, April 16, 2025 -- Droplet digital polymerase chain reaction (PCR) measurements of cell-free, circulating tumor DNA (ctDNA) can identify patients with melanoma and a high risk for recurrence before adjuvant targeted therapy, according to...
Read More

Tags:

Previous Article

CDC: Autism Prevalence Was 32.2 Per 1,000 8-Year-Olds in 2022

Next Article

Flares Occur Frequently in Generalized Pustular Psoriasis

Related Posts

Gynecological Disorders Can Increase Risk for Cardiovascular, Cerebrovascular Disease

Gynecological Disorders Can Increase Risk for Cardiovas...

Feb 28, 2025  0

Decline in BMI, Waist Circumference Seen in Decade Before Dementia

Decline in BMI, Waist Circumference Seen in Decade Befo...

Feb 9, 2025  0

COVID-19 Vaccination Not Linked to Major Structural Birth Defects

COVID-19 Vaccination Not Linked to Major Structural Bir...

Mar 14, 2025  0